151 related articles for article (PubMed ID: 34779031)
1. Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.
Moulis G; Germain J; Rueter M; Lafaurie M; Aroichane M; Comont T; Mahévas M; Viallard JF; Chèze S; Ebbo M; Audia S; Leclerc-Teffahi S; Sommet A; Beyne-Rauzy O; Michel M; Godeau B; Lapeyre-Mestre M;
Am J Hematol; 2022 Feb; 97(2):E40-E44. PubMed ID: 34779031
[No Abstract] [Full Text] [Related]
2. Eltrombopag in chronic idiopathic thrombocytopenic purpura.
Panzer S; Pabinger I
Lancet; 2009 Feb; 373(9664):607-8. PubMed ID: 19231614
[No Abstract] [Full Text] [Related]
3. Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND study.
Meyer O; Wong RSM; Khelif A; Stankovic M; Maier J; Saleh MN; Bussel JB
Br J Haematol; 2022 Jan; 196(2):448-452. PubMed ID: 34458977
[No Abstract] [Full Text] [Related]
4. Severe cutaneous toxicity related to Eltrombopag.
Meyer SC; Rovó A; Tsakiris DA; Scherer K; Tichelli A; Holbro A
Br J Haematol; 2013 Feb; 160(3):412-4. PubMed ID: 23151239
[No Abstract] [Full Text] [Related]
5. Eltrombopag--an oral thrombopoietin agonist.
Sharma V; Randhawa H; Sharma A; Aggarwal S
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):743-6. PubMed ID: 22913204
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.
Cook L; Cooper N
Drug Des Devel Ther; 2010 Jul; 4():139-45. PubMed ID: 20689640
[TBL] [Abstract][Full Text] [Related]
7. Successful discontinuation of eltrombopag in one child with refractory primary immune thrombocytopenia and literature review.
Wang X; Liu X; Wang L; Wang JY; Li A
Blood Coagul Fibrinolysis; 2019 Mar; 30(2):71-74. PubMed ID: 30720490
[TBL] [Abstract][Full Text] [Related]
8. Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids.
Wong TF; Majewska R; Tomiyama Y
Int J Hematol; 2021 Aug; 114(2):152-163. PubMed ID: 33851348
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study.
Grainger JD; Blanchette VS; Grotzinger KM; Roy A; Bussel JB
Br J Haematol; 2019 Apr; 185(1):102-106. PubMed ID: 30592022
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
[TBL] [Abstract][Full Text] [Related]
11. Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.
Lambert MP; Witmer CM; Kwiatkowski JL
Am J Hematol; 2017 Jun; 92(6):E88-E91. PubMed ID: 28240793
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia.
Chen M; Fang JP; Zhou CX; Li XY; Lin SF; Xu LH
Hematology; 2021 Dec; 26(1):31-36. PubMed ID: 33357172
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.
González-López TJ; Alvarez-Román MT; Pascual C; Sánchez-González B; Fernández-Fuentes F; Jarque I; Pérez-Rus G; Pérez-Crespo S; Bernat S; Hernández-Rivas JA; Andrade MM; Cortés M; Gómez-Nuñez M; Olivera P; Martínez-Robles V; Fernández-Rodríguez A; Fuertes-Palacio MA; Fernández-Miñano C; de Cabo E; Fisac R; Aguilar C; Bárez A; Peñarrubia MJ; García-Frade LJ; González-Porras JR
Eur J Haematol; 2016 Sep; 97(3):297-302. PubMed ID: 26709028
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Visco C; Rodeghiero F; Romano A; Valeri F; Merli M; Quaresimini G; Volpetti S; Santi RM; Carli G; Lucchini E; Passamonti F; Rambaldi A; Motta G; Borchiellini A; d'Amore ESG; Ruggeri M
Blood; 2019 Nov; 134(20):1708-1711. PubMed ID: 31570488
[TBL] [Abstract][Full Text] [Related]
15. Two new drugs for chronic ITP.
Med Lett Drugs Ther; 2009 Feb; 51(1305):10-1. PubMed ID: 19197233
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
Dmytrijuk A; Robie-Suh K; Rieves D; Pazdur R
Oncology (Williston Park); 2009 Nov; 23(13):1171-7. PubMed ID: 20043468
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study.
Cheng X; Yan K; Ma J; Chen Z; Zhao L; Wang X; Wu R
Int J Immunopathol Pharmacol; 2019; 33():2058738419872120. PubMed ID: 31438744
[TBL] [Abstract][Full Text] [Related]
18. Real-world evidence on clinical outcomes in immune thrombocytopenia treated with thrombopoietin receptor agonists.
Forsythe A; Schneider J; Pham T; Bhor M; Said Q; Allepuz A; Socorro O Portella MD; Kwon CS; Roy AN
J Comp Eff Res; 2020 May; 9(7):447-457. PubMed ID: 32175766
[No Abstract] [Full Text] [Related]
19. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
20. Immune thrombocytopenia in two infant cases managed with eltrombopag.
Ceglie G; Nocentini G; De Gennaro F; Clemente V; Di Mauro M; Palumbo G
Pediatr Blood Cancer; 2021 Sep; 68(9):e29120. PubMed ID: 34047051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
